Risk aversion and COVID‐19 vaccine hesitancy

Anthony Lepinteur; Liyousew G. Borga; Andrew E. Clark; Claus Vögele; Conchita D’Ambrosio

doi:10.1002/hec.4693

journal article Open Access May 05, 2023

Risk aversion and COVID‐19 vaccine hesitancy

Anthony Lepinteur

Health Economics Vol. 32 No. 8 pp. 1659-1669 · Wiley

View at Publisher Save 10.1002/hec.4693

Abstract

AbstractWe here investigate the role of risk aversion in COVID‐19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID‐19 infection and vaccination side‐effects involve probabilistic elements. In large‐scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID‐19 infection is perceived as involving greater risk than is vaccination.

Topics

No keywords indexed for this article. Browse by subject →

References

30

[1]

Preference Parameters and Behavioral Heterogeneity: An Experimental Approach in the Health and Retirement Study

R. B. Barsky, F. T. Juster, M. S. Kimball et al.

The Quarterly Journal of Economics 10.1162/003355397555280

[2]

10.1257/aer.102.5.2083

[3]

10.1038/s41598‐022‐16572‐x

[4]

10.1080/10410236.2010.521906

[5]

10.1006/pmed.1999.0535

[6]

Chen F. "Applying lessons from behavioral economics to increase flu vaccination rates" Health Promotion International (2017)

[7]

10.1002/hec.4405

[8]

10.1111/j.1542‐4774.2011.01015.x

[9]

10.1023/a:1011109625844

[10]

10.1007/s10654‐020‐00671‐y

[11]

10.1371/journal.pone.0248892

[12]

10.1093/qje/qjy013

[13]

10.1016/j.puhe.2021.07.035

[14]

10.1080/10410236.2017.1384353

[15]

10.3390/vaccines9030210

[16]

10.1101/2021.04.05.21254918

[17]

10.1002/(sici)1099‐1050(199902)8:1<9::aid‐hec396>3.0.co;2‐x

[18]

10.1038/s41467‐020‐20226‐9

[19]

10.1002/hec.4238

[20]

10.1016/j.bbi.2021.03.008

[21]

10.1371/journal.pone.0170550

[22]

10.1016/s2468‐2667(21)00012‐8

[23]

10.1098/rsif.2012.0115

[24]

10.3390/vaccines9030300

[25]

10.1177/1948550621999622

[26]

10.1016/j.socec.2012.05.001

[27]

10.3390/ijerph182312450

[28]

Vögele C. Lutz A. Yin R. &D’Ambrosio C.(2020).How do different confinement measures affect people in Luxembourg France Germany Italy Spain and Sweden? First COME‐HERE Report. Retrieved from:wwwen.uni.lu/research/fhse/dbcs/pandemic/research_papers

[29]

Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?

Charles Shey Wiysonge, Duduzile Ndwandwe, Jill Ryan et al.

Human Vaccines & Immunotherapeutics 10.1080/21645515.2021.1893062

[30]

10.1111/aphw.12262

Metrics

8

Citations

30

References

Details

Published: May 05, 2023
Vol/Issue: 32(8)
Pages: 1659-1669
License: View

Authors

A

Anthony Lepinteur

Department of Behavioural and Cognitive Sciences University of Luxembourg Esch‐sur‐Alzette Luxembourg

L

Liyousew G. Borga

Luxembourg Institute of Health Strassen Luxembourg

A

Andrew E. Clark

Department of Behavioural and Cognitive Sciences University of Luxembourg Esch‐sur‐Alzette Luxembourg; Paris School of Economics – CNRS Paris France

C

Claus Vögele

Department of Behavioural and Cognitive Sciences University of Luxembourg Esch‐sur‐Alzette Luxembourg

C

Conchita D’Ambrosio

Department of Behavioural and Cognitive Sciences University of Luxembourg Esch‐sur‐Alzette Luxembourg

Funding

Agence Nationale de la Recherche Award: ANR‐21‐CO16‐0002

Fonds National de la Recherche Luxembourg Award: 14840950 ‐ COME‐HERE

André Losch Fondation

Cite This Article

Anthony Lepinteur, Liyousew G. Borga, Andrew E. Clark, et al. (2023). Risk aversion and COVID‐19 vaccine hesitancy. Health Economics, 32(8), 1659-1669. https://doi.org/10.1002/hec.4693

Risk aversion and COVID‐19 vaccine hesitancy

You May Also Like